CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
HeRO Vascular Access Device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00890045
NCT00890045N/ACompleted
CompareCT.gov

A Comparison Between the HeRO® Graft and Conventional Arteriovenous Grafts in Hemodialysis Patients

Merit Medical Systems, Inc.·interventional·Posted Apr 29, 2009·Updated Jan 29, 2024

In Brief

A clinical study evaluating HeRO Vascular Access Device and Conventional ePTFE hemodialysis graft for Renal Failure Chronic Requiring Hemodialysis. Completed, enrolled 72 participants across 11 sites.

Detailed Summary

Compare the HeRO Vascular Access Device to a conventional ePTFE graft.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Failure Chronic Requiring Hemodialysis
CountriesUnited States
CollaboratorsCryoLife, Inc.

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 29, 2009
Enrollment StartJul 1, 2004
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 17.2 years ago

Interventions

HeRO Vascular Access Devicedevice

HeRO Vascular Access Device

Conventional ePTFE hemodialysis graftdevice

Conventional ePTFE hemodialysis graft